Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.QRxPharma files MoxDuo IR NDA with FDA
MoxDuo IR is an immediate-release Dual Opioid pain therapy comprised of a patented 3:2 fixed ratio combination of morphine and oxycodone. The company’s NDA Chemistry, Manufacturing and Controls
MoxDuo IR is an immediate-release Dual Opioid pain therapy comprised of a patented 3:2 fixed ratio combination of morphine and oxycodone. The company’s NDA Chemistry, Manufacturing and Controls
RxSafe’s core technology automatically stores, retrieves, and tracks pharmacy inventory down to the pill or package, while the he high-density storage systems handle pharmacy inventory in native packaging.
The Western European office headquarters will reside in France, the company said. Usana Health Sciences chief executive officer Dave Wentz said they are very excited about the decision
The new distribution center will be engaged in distributing pharmaceutical products as well as CII-CV controlled substances and temperature controlled products to all 50 states and Puerto Rico.
Ellis will expand ImpactRx through its next phase of growth including the expansion of its Consulting Analytics business, which is fueled by the company’s proprietary ImpactData. From 2002
The EC approval has been granted for linagliptin in combination with metformin and metformin plus sulfonylurea. The product will be marketed under Trajenta trade name in Europe. The
D-Sorb, avalaibale in small easy-to-swallow softgels, provides 2000 IUs of Vitamin D3. The new Vitamin D supplement features SourceOne Global Partners’ VESIsorb lipid-based delivery system, which provides for
Earlier, Shire‘s Firazyr has been granted orphan drug status in the EU and US as a treatment for acute HAE. Firazyr is supplied in a pre-filled syringe that
The drug is designed to treat active rheumatoid arthritis and comes under a category of disease modifying anti-rheumatic drugs (DMARDS). The clinical studies demonstrate that Iremod can relieve
Baxa develops pharmacy technology including ExactaMix compounder, devices which automate multi-ingredient nutritional solution compounding and the DoseEdge Pharmacy Workflow Manager, an integrated system for managing IV and oral